[
    [
        {
            "time": "",
            "original_text": "智飞生物董事长蒋仁生：汇率波动对公司进口疫苗没影响",
            "features": {
                "keywords": [
                    "智飞生物",
                    "董事长",
                    "蒋仁生",
                    "汇率波动",
                    "进口疫苗"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智飞生物董事长蒋仁生：汇率波动对公司进口疫苗没影响",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业:医药政策进入密集落地期,聚焦科创板、医药创新和医药消费",
            "features": {
                "keywords": [
                    "医药生物",
                    "行业",
                    "医药政策",
                    "密集落地期",
                    "科创板",
                    "医药创新",
                    "医药消费"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业:医药政策进入密集落地期,聚焦科创板、医药创新和医药消费",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]